Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Capital Employed (2024 - 2025)

CG Oncology filings provide 2 years of Return on Capital Employed readings, the most recent being 26.14% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 800.0% to 26.14% in Q4 2025 year-over-year; TTM through Dec 2025 was 26.14%, a 800.0% decrease, with the full-year FY2025 number at 25.7%, down 53.0% from a year prior.
  • Return on Capital Employed hit 26.14% in Q4 2025 for CG Oncology, up from 26.29% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 14.6% in Q2 2024 to a low of 26.29% in Q3 2025.